Cite
Huang J, Khan A, Au BC, et al. Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34. Mol Ther Methods Clin Dev. 2017;5:241-258doi: 10.1016/j.omtm.2017.05.003.
Huang, J., Khan, A., Au, B. C., Barber, D. L., López-Vásquez, L., Prokopishyn, N. L., Boutin, M., Rothe, M., Rip, J. W., Abaoui, M., Nagree, M. S., Dworski, S., Schambach, A., Keating, A., West, M. L., Klassen, J., Turner, P. V., Sirrs, S., Rupar, C. A., Auray-Blais, C., Foley, R., & Medin, J. A. (2017). Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34. Molecular therapy. Methods & clinical development, 5241-258. https://doi.org/10.1016/j.omtm.2017.05.003
Huang, Ju, et al. "Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34." Molecular therapy. Methods & clinical development vol. 5 (2017): 241-258. doi: https://doi.org/10.1016/j.omtm.2017.05.003
Huang J, Khan A, Au BC, Barber DL, López-Vásquez L, Prokopishyn NL, Boutin M, Rothe M, Rip JW, Abaoui M, Nagree MS, Dworski S, Schambach A, Keating A, West ML, Klassen J, Turner PV, Sirrs S, Rupar CA, Auray-Blais C, Foley R, Medin JA. Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34. Mol Ther Methods Clin Dev. 2017 May 12;5:241-258. doi: 10.1016/j.omtm.2017.05.003. eCollection 2017 Jun 16. PMID: 28603745; PMCID: PMC5453867.
Copy
Download .nbib